Bausch Health
310 hedge funds and large institutions have $4.2B invested in Bausch Health in 2018 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 72 increasing their positions, 117 reducing their positions, and 69 closing their positions.
57% more capital invested
Capital invested by funds: $2.67B → $4.2B (+$1.53B)
3.8% less ownership
Funds ownership: 47.99% → 44.18% (-3.8%)
5% less funds holding
Funds holding: 326 → 310 (-16)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
23% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 69
38% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 117
56% less call options, than puts
Call options by funds: $440M | Put options by funds: $1B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$58.9M |
| 2 |
JP Morgan Chase
New York
|
+$40.1M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$34.2M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$27.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$24.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$94M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$55.5M |
| 3 |
Walleye Trading
New York
|
-$55M |
| 4 |
Barclays
London,
United Kingdom
|
-$41.3M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$27.7M |
BHC Hedge Fund Activity: Q2 2018 in Review
310 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2018, worth a combined $4.2B — up 57% from $2.67B a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of BHC and 53 opened new positions — a net loss of 16 holders — while 117 trimmed existing stakes and 72 added.
The largest buyer was Fidelity International, opening a new position worth an estimated $58.9M. The largest seller was Nomura Holdings, exiting entirely with an estimated $94M sold.
- 310 institutional investors held Bausch Health (BHC) as of Q2 2018, down from 326 in Q1 2018.
- Funds reported $4.2B of Bausch Health stock for Q2 2018, up 57% quarter-over-quarter.
- 53 funds opened new Bausch Health positions in Q2 2018 and 69 closed out, a net change of -16 holders.
- The largest Bausch Health buyer in Q2 2018 was Fidelity International, an estimated $58.9M added.
- The largest Bausch Health seller in Q2 2018 was Nomura Holdings, an estimated $94M sold.
Based on aggregated 13F filings for Q2 2018.